Concept OB
RxNorm 1314666· VITAMIN MINERAL SUPPLEMENT· ORAL
Vitamin C [EPC], Vitamin B12 [EPC], Nicotinic Acid [EPC] · U.S. Pharmaceutical Corporation
Indications and usage
INDICATIONS: Concept OBTM is a prenatal supplement designed to improve the nutritional status for women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Concept OBTM may also be used to improve the nutritional status of women before conception.
Dosage and administration
DOSAGE AND ADMINISTRATION: Adults (persons over 12 years of age), One (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.
Warnings
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. WARNING: Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. PRECAUTIONS: General: Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.
Contraindications
CONTRAINDICATIONS: Concept OBTM is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- atrial septal defect2
- foetal exposure during pregnancy2
- maternal exposure during pregnancy2
- neonatal respiratory distress syndrome2
- pre-eclampsia2
- abdominal pain lower1
- abnormal behaviour1
- affect lability1
- alopecia1
- anger1
- anxiety1
- arrhythmia1
- autism spectrum disorder1
- caesarean section1
- chest discomfort1
- chordee1
Adverse reactions (label)
Adverse Reactions: Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Concept OBTM after meals may control occasional G.I. disturbances. Concept OBTM is best absorbed when taken at bedtime.
KR · 한국Products in Korea (2376)
- 리버쿨에스연질캡슐(유)한풍제약
- 리버쿨에스연질캡슐(유)한풍제약
- 헤모로얄캡슐(유)한풍제약
- 헤모로얄캡슐(유)한풍제약
- 콘트로그린연질캡슐(유)한풍제약
- 콘트로그린연질캡슐(유)한풍제약
- 리버쿨포르테연질캡슐(유)한풍제약
- 리버쿨포르테연질캡슐(유)한풍제약
- 리버쿨포르테연질캡슐(유)한풍제약
- 리버쿨포르테연질캡슐(유)한풍제약
- 류마콘틴정(유)한풍제약
- 류마콘틴정(유)한풍제약
- 콘트로렉스연질캡슐(유)한풍제약
- 콘트로플렉스연질캡슐(유)한풍제약
- 에코파워600정(유)한풍제약
- 에코파워600정(유)한풍제약
- 에코파워600정(유)한풍제약
- 독터아민연질캡슐(주)경보제약
- 독터아민연질캡슐(주)경보제약
- 리버포유연질캡슐(주)경보제약
View more: Full FDA label on DailyMed →Label effective 20221108